The beer giant said it would redirect funds to vaccine outreach.
The new equity and debt capital "means that any talk of an imminent bankruptcy for AMC is completely off the table."
Merck's announcement that it is shelving its two vaccine candidates "marks a shocking setback for one of the most storied vaccine makers."
"I think the right thing to do is for United Airlines, and for other companies, to require [COVID] vaccines."
The December jobs report shows "the economy’s not just tapping on the brakes, but actually has been thrown into reverse."
The biotech is preparing for the global launch of its potential COVID-19 vaccine.
Public health authorities were notified to prepare to distribute a coronavirus vaccine as early as late October.
The pharma giant agreed to pay Oxford Biomedica $20 million to reserve 1,000 liters of production capacity.
The initial 100 million doses ordered is valued at $1.95 billion.
After lagging behind other companies, J&J now expects to begin a late-stage study of its vaccine candidate in September.
The world's largest vaccine maker is no longer on the COVID sidelines after acquiring an Austrian biotech and teaming up with a nonprofit.
Interim data from a Phase 1 study showed Moderna's vaccine candidate stimulated an immune response against the virus in people.
